期刊文献+

干细胞相关治疗技术的临床应用前景 被引量:1

原文传递
导出
摘要 随着经济的发展、人民生活水平的提高和寿命的延长,代谢性和退行性疾病的发病率不断上升,这些疾病涉及特定组织或细胞的损伤或破坏,现有的治疗手段不能恢复受损细胞的功能或补足细胞的数量,故不能从根本上治愈疾病。近年来,随着干细胞与再生医学研究的兴起,人们看到了治愈这些疾病的希望。本文将对干细胞的研究进展和临床应用前景进行评述。
出处 《中国糖尿病杂志》 CAS CSCD 北大核心 2010年第9期641-644,共4页 Chinese Journal of Diabetes
基金 国家863计划资助项目(2006AA02A112) 国家自然科学基金资助项目(30771032,30700879)
  • 相关文献

参考文献27

  • 1Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science, 1998, 282 : 1145-1147.
  • 2Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 2006, 126: 663-676.
  • 3Okita K, Ichisaka T, Yamanaka S. Generation of germline- competent induced pluripotent stem cells. Nature, 2007, 448: 313-317.
  • 4Wernig M, Meissner A, Foreman R, et al. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature, 2007, 448:318-324.
  • 5Soria B, Roche E, Berna G, et al. Insulin secreting cells derived from embryonic stem cells normalize glycemia in strepto zotoein-induced diabetic mice. Diabetes, 2000, 49 : 157-162.
  • 6Assady S, Maor G, Amit M, et al. Insulin production by human embryonic stem cells. Diabetes, 2001, 50:1691-1697.
  • 7Mao GH, Chen GA, Bai HY, et al. The reversal of hyperglycaemia in diabetic mice using PLGA scaffolds seeded with isletlike cells derived from human embryonic stem cells. Biomaterials, 2009, 30:1706- 1714.
  • 8Blyszczuk P, Czyz J, Kania G, et al. Expression of Pax4 in embryonic stem cells promotes differentiation of nestin-positive progenitor and insulin producing cells. Proc Natl Acad Sci USA, 2003, 100..998 1003.
  • 9Kwon YD, Oh SK, Kim HS, et al. Cellular manipulation of human embryonic stem cells by TAT-PDX1 protein transduction. Mol Ther, 2005, 12:28-32.
  • 10Brolen GK, Heins N, Edsbagge J, et al. Signals from the em bryonic mouse pancreas induce differentiation of human embryonic stem cells into insulin producing β-cell-like cells. Diabetes, 2005, 54 : 2867-2874.

同被引文献16

  • 1Weissman I L. Stem cells:units of development units of regenera- tion, and unitsin evolution[J]. Cell, 2000,100 : 157- 168.
  • 2Hare J M, Traverse J H, Henry T D, et al. A randomized, double -blind, placebo- controlled study of intravenous adult human mesenchymal stem cells(prochymal) after acute myocardial infarc- tion[J]. J Am Coil Cardiol,2009,54:2277-2286.
  • 3Macehiarini P, Jungebluth P, Go T, et al. Clinical transplantation of a tissue- engineered airway [J]. Lancet, 2008, 9655: 2023 - 2030.
  • 4Snowden J A, Martin R E, Watt S M. Clinical stem cell therapies for se- vere autoimmune diseases[J]. Transfus Med,2009,19:223-234.
  • 5Ren Y X, Finckenstein F G, Abdueva D A, et al. Mouse mesen chymal stem cells expressing PAX - FKHR form alveolar rhab domyosarcomas by cooperating with secondary mutations [J]. Cancer Res,2008,68(16) :6587-6597.
  • 6Djouad F, Plence P, Bony C, et al. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals [J]. Blood, 2003,102 (10) : 3837- 3844.
  • 7Beggs K J, Lyubimov A, Borneman J N, et al. Immunologic consequences of multiple, high - dose administration of allogeneic mesenchymal stem cells to baboons[J]. Cell Transplant ,2006,15(9):711-721.
  • 8Devine S M, Bartholomew A M, Mahmud N, et al. Mesenchymal stem cells are capable of homing to the bone marrow of non- hu- man primates following systemic infusion[J]. Exp Hematol,2001, 29(2):244-255.
  • 9Ramaswamy R, Fazekasoz H, Lam E W, et al. Mesenchvreal stem cells inhibit dendritic cell differentiation and function by preventing entry into the cell cycle[J]. Transplantation,2007,83(1):71-76.
  • 10Fang B, Song Y, Liao L, et al. Favorable response to human adi- pose tissue-derived mesenchymal stem cells in steroid-refractory acute graft-versus- host disease[J]. Transplant Proc, 2007,39 (10) :3358-3362.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部